Nombre del producto:2,2,2-trifluoro-1-(piperidin-4-yl)ethanone oxalate

IUPAC Name:bis(2,2,2-trifluoro-1-(piperidin-4-yl)ethan-1-one); oxalic acid

CAS:1182349-50-3
Fórmula molecular:C16H22F6N2O6
Pureza:95%+
Número de catálogo:CM363312
Peso molecular:452.35

Unidad de embalaje Stock disponible Precio($) Cantidad
CM363312-25mg in stock șǕ
CM363312-100mg in stock ǯșƏ
CM363312-250mg in stock ȀŭȀ
CM363312-1g 1-2 Weeks ňșŔ
CM363312-5g 1-2 Weeks ǯșƏƞ
CM363312-10g 1-2 Weeks Ȁŭǯș

Sólo para uso en I+D..

Formulario de consulta

   refresh    

Detalles del producto

Núm. De CAS :1182349-50-3
Fórmula molecular:C16H22F6N2O6
Punto de fusión:-
Código de sonrisas:OC(=O)C(O)=O.FC(F)(F)C(=O)C1CCNCC1.FC(F)(F)C(=O)C1CCNCC1
Densidad:
Número de catálogo:CM363312
Peso molecular:452.35
Punto de ebullición:
Nº Mdl:MFCD11501649
Almacenamiento:

Category Infos

Piperidines
Piperidine is an azacycloalkane that is cyclohexane in which one of the carbons is replaced by a nitrogen. Although piperidine is a common organic compound, it is an immensely important class of compounds medicinally: the piperidine ring is the most common heterocyclic subunit among FDA approved drugs.
Piperidine,Piperidine Price
if you want to know the latest news about piperidine and piperidine price, please come to our website and get a quote for free.
Fluorinated Compounds
Fluorine is the most electronegative element in the periodic table, and the fluorine atom has a small atomic radius, so fluorine-containing organic compounds have many wonderful properties. For example, the introduction of fluorine atoms or fluorine-containing groups into drug molecules can improve the permeability to cell membranes, metabolic stability and bioavailability; in addition, the introduction of fluorine atoms will improve the lipid solubility of the compound and promote its absorption in the body. The speed of delivery changes the physiological effect. In the field of medicinal chemistry, the introduction of fluorine atoms into organic molecules is an important direction for the development of new anticancer drugs, antitumor drugs, antiviral agents, anti-inflammatory drugs, and central nervous system drugs.